End of Stabilisation Notice

RNS Number : 7019E

Circassia Pharmaceuticals Plc

11 April 2014

 



NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT OR ANY COPY OF IT

11 April 2014

CIRCASSIA PHARMACEUTICALS PLC

End of Stabilisation Notice

Pursuant to Article 9(3) of Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC), and MAR 2.3.5 (3) of the Financial Conduct Authority Code of Market Conduct, J.P. Morgan Securities plc (Manuel Esteve: Telephone: [phone]), the Stabilising Manager, hereby gives notice that it undertook stabilisation (within the meaning of the rules of the Financial Conduct Authority) in relation to the offer of the following securities, as set out below:

Issuer:	Circassia  Pharmaceuticals plc
Securities/ISIN:	Ordinary Shares of 0.08 pence each (ISIN: GB00BJVD3B28)
Description of offer:	Initial Public Offering
Offer price:	310 pence per Ordinary Share
Stabilising Manager:	J.P. Morgan Securities Plc
Stabilisation period:	13 March 2014 to 11 April 2014
Stabilisation started:	13 March 2014
Stabilisation last occurred:	11 April 2014

For each of the dates during which stabilisation transactions were carried out, the price range was as follows:

Date	Minimum Price Paid (GBp)	Maximum Price Paid (GBp)
13/03/2014	309.00	310.00
14/03/2014	309.00	310.00
17/03/2014	307.00	310.00
18/03/2014	309.00	310.00
19/03/2014	309.00	310.00
20/03/2014	308.00	310.00
21/03/2014	307.00	308.50
24/03/2014	304.00	307.25
25/03/2014	304.50	306.00
26/03/2014	303.00	305.25
27/03/2014	290.25	303.00
28/03/2014	292.75	299.00
31/03/2014	298.00	303.00
01/04/2014	296.00	303.00
02/04/2014	299.50	301.00
03/04/2014	298.50	301.00
04/04/2014	301.00	304.00
07/04/2014	303.00	306.00
08/04/2014	306.00	308.00
09/04/2014	306.50	310.00
10/04/2014	309.00	310.00
11/04/2014	305.00	310.00

Accordingly, J.P. Morgan Securities plc, as Stabilising Manager, has exercised the Over-allotment Option (as described in the Circassia Pharmaceuticals plc prospectus) in respect of 633,380 Ordinary Shares in Circassia Pharmaceuticals Plc.

Disclaimer

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not for distribution, directly or indirectly, in or into the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia) (the "United States"), Australia, Canada, Japan or other excluded territories. This announcement does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States, Australia, Canada, Japan or other excluded territories.

The securities of the Issuer have not been and will not be registered under the U.S. Securities Act of 1933 (the "Securities Act") and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The securities referred to herein have not been registered under the applicable securities laws of Australia, Canada or Japan and, subject to certain exceptions, may not be offered or sold within Australia, Canada or Japan or to any national, resident or citizen of Australia, Canada or Japan. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions.

 

END

 

 

MSCZMGMDVMLGDZM